NEW YORK (GenomeWeb) – Researchers at Oregon Health & Science University and elsewhere have tested the clinical utility of genome sequencing for preconception carrier screening, finding that it offers improved sensitivity over targeted testing but also generates significant numbers of variants of unknown significance.